US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avid Bioservices, Inc.

12.49

+0.0000

Volume:- -

Turnover:38.32M

Market Cap:798.90M

PE:-5.22

High:12.49

Open:12.49

Low:12.49

Close:12.49

Loading ...

Overview Company News Filings

CVKD: Preparing for Phase 3 Trial of Tecarfarin…

Zacks Small Cap Research

Cabaletta Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Lifecore Biomedical to Report Financial Results for Third Quarter of Fiscal 2025 on April 3, 2025

Theratechnologies Receives FDA Approval for EGRIFTA WR™ (Tesamorelin F8) to Treat Excess Visceral Abdominal Fat in Adults with HIV and Lipodystrophy

OXB honoured at 2025 CDMO Leadership Awards in 'Cell & Gene Therapy – Global' category

Press Release: Integer Holdings Corporation Enhances Capitalization Structure with the Closing of $1.0 Billion Convertible Senior Notes Offering

Humanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome

Samsung Biologics Likely to Benefit From Rising CDMO Penetration -- Market Talk

Integer Holdings Corporation Announces Upsize and Pricing of Convertible Notes Offering

Press Release: Cadrenal Therapeutics Reports Full Year 2024 Results, Business Highlights, and Path Forward for Clinical Advancement of Tecarfarin

NVO Stock Slips 4% as Roche Inks Obesity Drug Deal With Zealand

Asian Penny Stocks Spotlight: Viva Biotech Holdings And Two More To Consider

Simply Wall St.

Viking Therapeutics Signs Broad Manufacturing Agreement With CordenPharma to Support Commercialization of VK2735

BioHarvest Sciences to Participate in 37th Annual Roth Conference on March 16-18, 2025

Bionova Opens Fremont Process Development and Pilot Plant

BioHarvest In Vitro Testing Shows Proprietary Olive Cell Compound Reduces Fat Accumulation in Liver Cells

Full-Year 2024 Results - Progress on the implementation of the FOCUS-27 plan driven by enhanced effectiveness and financial discipline

Market Chatter: South Korea Aims to Be Among Top Five Global Bio Leaders

MT Newswires Live

Lifecore Biomedical to Participate in Upcoming Investor and Industry Conferences

Scorpius Holdings Engages Alliance Global Partners to Explore Strategic Alternatives

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CDMO/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CDMO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CDMO\",,,,,undefined,":{"symbol":"CDMO","market":"US","secType":"STK","nameCN":"Avid Bioservices, Inc.","latestPrice":12.49,"timestamp":1738702800000,"preClose":12.49,"halted":3,"volume":0,"delay":0,"floatShares":50623090,"shares":63963302,"eps":-2.394638,"marketStatus":"Halted","change":0,"latestTime":"02-04 16:00:00 EST","open":12.49,"high":12.49,"low":12.49,"amount":38317107.960278,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.394638,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1747036800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":12.49,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CDMO\",,,,,undefined,":{"symbol":"CDMO","floatShares":50623090,"roa":"-3.27%","roe":"-133.29%","lyrEps":-2.227139,"shares":63963302,"dividePrice":0,"high":12.49,"amplitude":0,"preClose":12.49,"low":12.49,"week52Low":5.9,"pbRate":"17.83","psRate":"5.31","week52High":12.51,"institutionHeld":0.9807,"latestPrice":12.49,"eps":-2.394638,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.394638,"open":12.49,"prevYearClose":12.35,"prevWeekClose":12.48,"prevMonthClose":12.48,"prevQuarterClose":12.35},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CDMO\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2524974387","title":"CVKD: Preparing for Phase 3 Trial of Tecarfarin…","url":"https://stock-news.laohu8.com/highlight/detail?id=2524974387","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524974387?lang=en_us&edition=fundamental","pubTime":"2025-03-31 22:24","pubTimestamp":1743431040,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics, Inc.  is a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible anticoagulant intended to prevent heart attacks, stroke, and death due to blood clots in patients suffering from rare cardiovascular conditions requiring chronic anticoagulation. These conditions include patients with left ventricular assist devices , patients with end-stage kidney disease  and atrial fibrillation , and patients with mechanical heart valves with difficult-to-control time in therapeutic range .The company is currently preparing for the Phase 3 TECarfarin Anticoagulation and Hemocompatibility with Left Ventricular Assist Devices  trial. Recently, Cardrenal announced a collaboration agreement with Abbott in which Abbott will assist Cadrenal with trial design, site identification, trial awareness, and HeartMate 3 expertise. Abbott is the maker of the HeartMate 3 LVAD, which is the only LVAD currently approved in the U.S.As of December 31, 2024, Cadrenal","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cvkd-preparing-phase-3-trial-142400100.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE0002141913.USD","LU1691799644.USD","SG9999002224.SGD","BK4082","LU2237957811.SGD","SG9999002232.USD","LU1914381329.SGD","IE00B4R5TH58.HKD","LU0868494617.USD","LU0170899867.USD","BK4588","LU1989763690.USD","ODD","SG9999004303.SGD","BK4007","CDMO","IE00BJJMRZ35.SGD","LU1989763427.SGD","CVKD","LU1023059063.AUD","LU1057294990.SGD","LU2468319806.SGD","IE00B2B36J28.USD","BK4585","IE00BJT1NW94.SGD","LU1721429741.USD","BK4504","LU2237957902.USD","BK4581","SGXZ23171101.USD","IE00BFTCPJ56.SGD","ABT","LU0266013472.USD","LU1061106388.HKD","BK4566","LU0234572021.USD","LU2133065610.SGD","BK4139","LU1721429402.USD","BK4592","BK4533","LU0122379950.USD","BK4568","LU2089984988.USD","BK4183","IE0009355771.USD","LU2112291526.USD"],"gpt_icon":0},{"id":"2523171969","title":"Cabaletta Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2523171969","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523171969?lang=en_us&edition=fundamental","pubTime":"2025-03-31 19:00","pubTimestamp":1743418800,"startTime":"0","endTime":"0","summary":"– FDA meeting to align on myositis registrational trial designs for rese-cel in 1H25 on track – – Enrolling approximately one patient per week across the RESET clinical development program since ACR C","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/31/3052139/0/en/Cabaletta-Bio-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDMO","LU0158827948.USD","LU1720051017.SGD","LU1732799900.SGD","LU0795875169.SGD","LU1732800096.USD","SLE","LU1720051108.HKD","BK4563","LU0225283273.USD","BK4516","LU0267386448.USD","IE00BKVL7J92.USD","BK4504","LU0971096721.USD","LU1074936037.SGD","LU1989772923.USD","LU2357305700.SGD","LU1363072403.SGD","LU0795875086.SGD","BK4139","LU0912757837.SGD","LU2271345857.HKD","LU2023251221.USD","CABA","BK4581","LU2028103732.USD","LU1162221912.USD","BK4585","BK4588","LU0098860793.USD","LU0314104364.USD","LU2089283258.USD","IE00BZ1G4Q59.USD","LU1989772840.SGD","LU1548497426.USD","LU2347655156.SGD","IMNM","LU0106261372.USD","BK4127","BK4077","LU0320765646.SGD","LU0106831901.USD","LU1668664300.SGD","LU2133065610.SGD","LU2111349929.HKD","LU2089284900.SGD","LU0158827781.USD","LU0006306889.USD","BK4534"],"gpt_icon":0},{"id":"2522530276","title":"Lifecore Biomedical to Report Financial Results for Third Quarter of Fiscal 2025 on April 3, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2522530276","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522530276?lang=en_us&edition=fundamental","pubTime":"2025-03-28 04:05","pubTimestamp":1743105900,"startTime":"0","endTime":"0","summary":"Webcast Scheduled for Thursday, April 3 at 4:30 p.m. Eastern. CHASKA, Minn., March 27, 2025  -- Lifecore Biomedical, Inc.  , a fully integrated contract development and manufacturing organization , today announced that it will report financial results for the third quarter of fiscal year 2025 on Thursday, April 3, 2025, after market close. At 4:30 p.m. Eastern Time that day, members of Lifecore’s senior management team will host a webcast to discuss financial results for the quarter and review recent corporate developments.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lifecore-biomedical-report-financial-results-200500244.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CDMO","BK4139","LFCR","BK4212","BK4121","CFO"],"gpt_icon":0},{"id":"2522902839","title":"Theratechnologies Receives FDA Approval for EGRIFTA WR™ (Tesamorelin F8) to Treat Excess Visceral Abdominal Fat in Adults with HIV and Lipodystrophy","url":"https://stock-news.laohu8.com/highlight/detail?id=2522902839","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522902839?lang=en_us&edition=fundamental","pubTime":"2025-03-26 05:45","pubTimestamp":1742939100,"startTime":"0","endTime":"0","summary":"New, improved formulation set to replace EGRIFTA SV. MONTREAL, March 25, 2025  -- Theratechnologies Inc.   , a commercial-stage biopharmaceutical company, today announced that the U.S. Food and Drug Administration  has approved the Company’s supplemental Biologics License Application  for the F8 formulation of tesamorelin for injection. The Company will commercialize the new formulation under the tradename EGRIFTA WR.Tesamorelin for injection is the only medication approved in the U.S. for the reduction of excess abdominal fat in adults with HIV who have lipodystrophy. The new formulation, EGRIFTA WR, is a daily injectable but only needs weekly reconstitution. It requires less than half the administration volume as the current F4 formulation, sold in the U.S. as EGRIFTA SV, which is reconstituted daily. Pharmacokinetic studies have shown bioequivalence of EGRIFTA WR to the original F1 formulation of tesamorelin for injection .The most commonly reported adverse reactions ofEGRIFTA WR in","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/theratechnologies-receives-fda-approval-egrifta-214500945.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MRK","IE00B1BXHZ80.USD","IE00BJJMRZ35.SGD","LU1023059063.AUD","LU2324357040.USD","BK4585","LU0203345920.USD","LU1057294990.SGD","LU2361045086.USD","IE0002141913.USD","LU1585245621.USD","LU1989771016.USD","LU1116320901.HKD","LU1093756168.USD","LU1061106388.HKD","LU1934455277.USD","LU0985320562.USD","CDMO","LU1066051498.USD","LU1934455194.USD","LU2468319806.SGD","LU1989772840.SGD","IE0009355771.USD","BK4550","LU2361044949.HKD","LU0965508806.USD","SG9999013999.USD","LU1116320737.USD","LU0965509101.SGD","LU1929549753.HKD","IE00BBT3K403.USD","LU1941712264.USD","LU2023250504.SGD","SG9999001176.SGD","THTX","LU0265550946.USD","LU2361044865.SGD","IE00BSNM7G36.USD","LU2106854487.HKD","LU0006306889.USD","LU1162221912.USD","SG9999001176.USD","SGXZ57979304.SGD","IE00BLSP4239.USD","LU1037948897.HKD","SG9999014575.USD","IE000M9KFDE8.USD","SG9999014542.SGD","SG9999014559.SGD","IE00BLSP4452.SGD"],"gpt_icon":0},{"id":"2521288010","title":"OXB honoured at 2025 CDMO Leadership Awards in 'Cell & Gene Therapy – Global' category","url":"https://stock-news.laohu8.com/highlight/detail?id=2521288010","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521288010?lang=en_us&edition=fundamental","pubTime":"2025-03-21 20:00","pubTimestamp":1742558400,"startTime":"0","endTime":"0","summary":"OXB honoured at 2025 CDMO Leadership Awards in 'Cell & Gene Therapy – Global' category Oxford, UK – 21 March 2025:OXB (LSE: OXB) (the \"Company\"), a quality and innovation-led cell and gene therapy CDM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/21/3047023/0/en/OXB-honoured-at-2025-CDMO-Leadership-Awards-in-Cell-Gene-Therapy-Global-category.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDMO","BK4139"],"gpt_icon":0},{"id":"2520964769","title":"Press Release: Integer Holdings Corporation Enhances Capitalization Structure with the Closing of $1.0 Billion Convertible Senior Notes Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2520964769","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520964769?lang=en_us&edition=fundamental","pubTime":"2025-03-19 09:30","pubTimestamp":1742347800,"startTime":"0","endTime":"0","summary":"Integer Holdings Corporation Enhances Capitalization Structure with the Closing of $1.0 Billion Convertible Senior Notes Offering. \"This transaction creates revolver capacity to enable us to continue executing our strategy while reducing our interest costs by meaningfully increasing the percentage of our debt at substantially lower interest rates,\" said Joe Dziedzic, president and CEO. \"We believe the strong demand from investors for this convertible bond offering demonstrates investors' confidence in Integer's strategy and financial strength.\". Upon conversion, the principal amount of the Notes will be paid in cash. As a result of the related capped call transactions, dilution upon a conversion of the Notes will be mitigated by the increased effective conversion price of the Notes to $189.44, a premi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0757428866.USD","LU1815336091.USD","LU1169589451.USD","LU1169590202.USD","LU0128526141.USD","BK4022","ITGR","LU0029874061.USD","BK4082","LU1559883803.SGD","CDMO","BK4232","LU0566484027.USD","R"],"gpt_icon":0},{"id":"2520331549","title":"Humanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2520331549","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520331549?lang=en_us&edition=fundamental","pubTime":"2025-03-17 19:00","pubTimestamp":1742209200,"startTime":"0","endTime":"0","summary":"Humanetics’ Novel Radioprotective Agent Being Developed with Funding from Department of Defense as Radiation Medical Countermeasure . Lifecore to Carry Out Tech Transfer and Analytical Method Activities, including Filling of Pilot Batch. CHASKA, Minn. and MINNEAPOLIS, March 17, 2025  -- Lifecore Biomedical, Inc.  , a fully integrated contract development and manufacturing organization , and Humanetics Corporation , an advanced clinical-stage pharmaceutical company, today announced that Humanetics has selected Lifecore to provide a range of CDMO services to support the continued development of BIO 300 for the prevention of acute radiation syndrome. Under the terms of the agreement, Lifecore will conduct technology transfer of the existing fill and finish process for BIO 300, including formulation development, gap assessment, and filling of a pilot batch. Lifecore will also undertake analytical method work including feasibility assessments designed to estimate future development work for","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/humanetics-selects-lifecore-biomedical-deliver-110000609.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","LU1169590202.USD","CFO","BIO","BK4139","LFCR","LU1169589451.USD","CDMO","BK4212","BK4121","BK4588"],"gpt_icon":0},{"id":"2520602335","title":"Samsung Biologics Likely to Benefit From Rising CDMO Penetration -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2520602335","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520602335?lang=en_us&edition=fundamental","pubTime":"2025-03-17 15:28","pubTimestamp":1742196480,"startTime":"0","endTime":"0","summary":"0728 GMT - Samsung Biologics is likely to benefit from rising contract development and manufacturing organization penetration, Nomura's analyst Cindy Park says in a research report. Nomura's view is partly based on strong global demand for large-scale contract manufacturing organizations, as pharmaceutical firms are increasingly transitioning into CDMOs to minimize risks related to high capex and uncertainties on drug approvals. CDMO penetration in global bio-pharmaceutical industry for mammalian cells will likely rise to 45% by 2030 from estimated 35% this year, with the South Korean contract development and manufacturing organization likely to be a key beneficiary. Nomura assumes coverage of the stock with a buy rating and a target price of KRW1,400,000.00. It previously held a neutral rating and a target price of KRW840,000.00. Shares closed 1.7% higher at KRW1,069,000.00. ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDMO","BK4139"],"gpt_icon":0},{"id":"2519581438","title":"Integer Holdings Corporation Announces Upsize and Pricing of Convertible Notes Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2519581438","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519581438?lang=en_us&edition=fundamental","pubTime":"2025-03-14 11:29","pubTimestamp":1741922940,"startTime":"0","endTime":"0","summary":"PLANO, Texas, March  13, 2025  (GLOBE NEWSWIRE) -- Integer Holdings Corporation (the “Company,” “Integer”) (NYSE: ITGR) today announced that it has priced an offering of $875.0 million aggregate princ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/14/3042725/26755/en/Integer-Holdings-Corporation-Announces-Upsize-and-Pricing-of-Convertible-Notes-Offering.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0757428866.USD","LU1559883803.SGD","LU0128526141.USD","LU1169589451.USD","LU0029874061.USD","CDMO","LU0566484027.USD","BK4082","ITGR","BK4139","LU1815336091.USD","LU1169590202.USD"],"gpt_icon":0},{"id":"2519695478","title":"Press Release: Cadrenal Therapeutics Reports Full Year 2024 Results, Business Highlights, and Path Forward for Clinical Advancement of Tecarfarin","url":"https://stock-news.laohu8.com/highlight/detail?id=2519695478","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519695478?lang=en_us&edition=fundamental","pubTime":"2025-03-14 04:05","pubTimestamp":1741896300,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics Reports Full Year 2024 Results, Business Highlights, and Path Forward for Clinical Advancement of Tecarfarin. Recent Collaboration Agreement with Abbott Global Enterprises Limited  in support of Phase 3 randomized, multicenter study, entitled TECH-LVAD. Recent FDA Type D Meeting provides additional guidance for advancing clinical development of tecarfarin. Cadrenal Therapeutics, Inc. , a biopharmaceutical company focused on the development of tecarfarin, a new Phase 3 ready oral vitamin K antagonist, today reported full year results for the period ended December 31, 2024, and provided a business update and highlights of the path forward for the clinical advancement of tecarfarin.Full Year 2024 Key Accomplishments and Recent Highlights. Cadrenal appointed James J. Ferguson, MD, FACC, FAHA, as Chief Medical Officer to lead the late-stage clinical development of tecarfarin and other indications in rare cardiovascular conditions requiring life-long anticoagulation the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002232.USD","BK4592","LU0266013472.USD","LU1057294990.SGD","BK4581","LU2237957811.SGD","BK4566","LU1721429741.USD","FORD","BK4585","ABT","ODD","IE00BFTCPJ56.SGD","LU0170899867.USD","LU2112291526.USD","03160","BK4533","CDMO","BK4504","LENZ","BK4604","LU1914381329.SGD","BK4183","IE00B2B36J28.USD","LU1691799644.USD","LU2089984988.USD","BK4139","LU1061106388.HKD","IE0009355771.USD","IE00BJT1NW94.SGD","SG9999002224.SGD","IE00BJJMRZ35.SGD","SG9999004303.SGD","SGXZ23171101.USD","LU0122379950.USD","BK4007","BK4082","LU1989763690.USD","IE0002141913.USD","LU2237957902.USD","LU0868494617.USD","LU0234572021.USD","LU1721429402.USD","CVKD","BK4588","LU1989763427.SGD","LU2133065610.SGD","LU2468319806.SGD","TM","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2519863829","title":"NVO Stock Slips 4% as Roche Inks Obesity Drug Deal With Zealand","url":"https://stock-news.laohu8.com/highlight/detail?id=2519863829","media":"Zacks","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519863829?lang=en_us&edition=fundamental","pubTime":"2025-03-14 01:23","pubTimestamp":1741886580,"startTime":"0","endTime":"0","summary":"Novo Nordisk’s NVO stock declined 4.3% on Wednesday after Roche RHHBY announced a license and collaboration deal worth $5.3 billion with Denmark’s Zealand Pharma to co-develop its lead obesity candidate petrelintide. Roche’s latest deal increases competition in the obesity space.Roche Buys Rights to Obesity Drug From Zealand Pharma. Amylin drugs work similarly to the popular GLP-1 drugs ruling the obesity space. The GLP-1 space is dominated by NVO and Eli Lilly LLY, with their popular obesity injections, Wegovy  and Zepbound , respectively. Like GLP-1 drugs mimica naturally occurring hormone, GLP-1, to regulate blood sugar and promote weight loss, amylin drugs mimic another natural hormone amylin, which is secreted at the same time as insulin in response to food intake. Amylin drugs are being considered the next generation of obesity medicines after the current GLP-1 medicines.NVO’s stock has plunged 44.4% in the past year compared with a decrease of 5.2% for the industry.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nvo-stock-slips-4-roche-172300319.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["03165","LU2264538146.SGD","LU0882574139.USD","LU2237443622.USD","LU0466842654.USD","LU2491049909.HKD","IE00BK4W5M84.HKD","LU0256863902.USD","BK4581","BK4599","SG9999015986.USD","LU2089984988.USD","LU1291159041.SGD","LU1551013425.SGD","LU2237443465.HKD","LU1868837136.USD","LU1814569148.SGD","LU0058720904.USD","LU2106854487.HKD","SG9999014898.SGD","LU2112291526.USD","LU0385154629.USD","VKTX","LU0417517546.SGD","LU2237443549.SGD","LU2602419157.SGD","IE00B4R5TH58.HKD","LU1548497426.USD","CDMO","BK4007","LU2491050154.USD","LU1127390331.HKD","LU2360106947.USD","NVO","LU1093756168.USD","LU1069344957.HKD","SG9999018865.SGD","LU1720051108.HKD","SGXZ51526630.SGD","LU0820561818.USD","RHHBY","SG9999017495.SGD","LU0061475181.USD","IE00BJLML261.HKD","LU2324357040.USD","SG9999001176.USD","ZLDPF","LU2023250504.SGD","SG9999015945.SGD"],"gpt_icon":1},{"id":"2518970647","title":"Asian Penny Stocks Spotlight: Viva Biotech Holdings And Two More To Consider","url":"https://stock-news.laohu8.com/highlight/detail?id=2518970647","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518970647?lang=en_us&edition=fundamental","pubTime":"2025-03-12 06:02","pubTimestamp":1741730522,"startTime":"0","endTime":"0","summary":"Amidst global economic uncertainties, Asian markets have shown resilience, with a focus on growth strategies to navigate challenges such as trade tensions and inflationary pressures. In this context, penny stocks—often representing smaller or newer companies—continue to capture investor interest due to their potential for significant returns. While the term may seem outdated, these stocks can offer a blend of affordability and growth potential when backed by strong financials.Click here to see the full list of 1,162 stocks from our Asian Penny Stocks screener.Let's uncover some gems from our specialized screener.Overview: Viva Biotech Holdings is an investment holding company that provides structure-based drug discovery services to biotech and pharmaceutical clients globally, with a market cap of HK$3.17 billion.Operations: The company's revenue is primarily generated from its Drug Discovery Services, which account for CN780.09 million, and its Contract Development Manufacture Organisa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance_sg","url":"https://finance.yahoo.com/news/asian-penny-stocks-spotlight-viva-220202503.html","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/asian-penny-stocks-spotlight-viva-220202503.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_sg","symbols":["BK4139","BK6520","BK6045","CDMO","VBIZF","E3B.SI","BK4121"],"gpt_icon":1},{"id":"2518413257","title":"Viking Therapeutics Signs Broad Manufacturing Agreement With CordenPharma to Support Commercialization of VK2735","url":"https://stock-news.laohu8.com/highlight/detail?id=2518413257","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518413257?lang=en_us&edition=fundamental","pubTime":"2025-03-11 19:03","pubTimestamp":1741690980,"startTime":"0","endTime":"0","summary":"Long-Term Agreement Secures Dedicated Capacity for Multi-Ton Annual Supply of VK2735 Active Pharmaceutical Ingredient. Secures Dedicated Fill/Finish Capacity for 100 Million Annual Autoinjector Supply and Additional 100 Million Annual Vial/Syringe Supply. Provides Annual Capacity of Over 1 Billion Oral Tablets. Viking to Make Prepayments Totaling $150 Million Between 2025-2028. \"We are excited to enter into this agreement with one of the world's leading CDMOs in the peptide space,\" said Brian Lian, Ph.D., chief executive officer of Viking Therapeutics. \"We have a long history of working with CordenPharma and are happy to extend and strengthen our relationship with this agreement. CordenPharma's established presence in commercial peptide manufacturing gives us confidence in their ability to deliver supply commensurate with what we anticipate will be significant commercial demand. In addition,CordenPharma's ability to provide dedicated capacity across the supply chain, from API through f","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/viking-therapeutics-signs-broad-manufacturing-110300658.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/viking-therapeutics-signs-broad-manufacturing-110300658.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","CDMO","BK4196","BK4551","BK4503","BK4023","BK4588","BK4139","BK4535","VKTX","API","AMN","BK4599"],"gpt_icon":0},{"id":"2517157728","title":"BioHarvest Sciences to Participate in 37th Annual Roth Conference on March 16-18, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2517157728","media":"Newsfile","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517157728?lang=en_us&edition=fundamental","pubTime":"2025-03-06 21:30","pubTimestamp":1741267800,"startTime":"0","endTime":"0","summary":"Vancouver, British Columbia and Rehovot, Israel-- - BioHarvest Sciences Inc. , a company pioneering its patented Botanical Synthesis technology platform, today announced that management has been invited to attend the 37th Annual Roth Conference taking place on March 16-18, 2025.CEO Ilan Sobel is scheduled to host one-on-one meetings with institutional investors throughout the duration of the event.37th Annual Roth Conference for Growth CompaniesDate: March 16-18, 2025Location: Laguna Cliffs Marriott Resort & Spa - Dana Point, CAFormat: 1x1s Meetings. This press release may contain \"forward-looking statements\". \"Forward-looking statements\" describe future expectations, plans, results, or strategies and are generally preceded by words such as \"may,\" \"future,\" \"plan\" or \"planned,\" \"will\" or \"should,\" \"expected,\" \"anticipates,\" \"draft,\" \"eventually\" or \"projected.\" You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumsta","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/bioharvest-sciences-participate-37th-annual-133000257.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bioharvest-sciences-participate-37th-annual-133000257.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BHST","BK4183","CDMO"],"gpt_icon":0},{"id":"2516794876","title":"Bionova Opens Fremont Process Development and Pilot Plant","url":"https://stock-news.laohu8.com/highlight/detail?id=2516794876","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516794876?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:30","pubTimestamp":1741095000,"startTime":"0","endTime":"0","summary":"Bionova leadership team celebrates ribbon cutting at new Fremont, CA Process Development & Pilot Plant facility with community leaders. . FREMONT, Calif., March 04, 2025----Bionova Scientific, an Asahi Kasei company and boutique commercial-scale biologics contract development and manufacturing organization , has announced the opening of a new facility in Fremont, California. The 55,000 sq. ft. process development and pilot plant will significantly expand the company’s ability to advance early-stage biologics assets to first-in-human trials and facilitate the future expansion of its manufacturing capacity.\"Many of our customers are early-stage biopharmaceutical innovators who need agile partners who can quickly provide process development and reliable manufacturing operations that are scaleable, without the need to tech transfer to another CDMO as their programs mature,\" commented Darren Head, Chairman & President of Bionova. \"This new facility enhances our capacity to serve early-stage","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bionova-opens-fremont-process-development-133000877.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CDMO","AHKSF","BK4090","AHKSY","BK4139"],"gpt_icon":0},{"id":"2516467120","title":"BioHarvest In Vitro Testing Shows Proprietary Olive Cell Compound Reduces Fat Accumulation in Liver Cells","url":"https://stock-news.laohu8.com/highlight/detail?id=2516467120","media":"Newsfile","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516467120?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:30","pubTimestamp":1741095000,"startTime":"0","endTime":"0","summary":"Non-Alcoholic Fatty Liver Disease  Affects 30-40% of U.S. Adults, Driving Significant Market Need for BioHarvest's Future Olive Cell Product Targeting Liver Health. The Company attributes the positive test results of reducing fat accumulation in liver cells to the high levels of Verbascoside  in BioHarvest's Olive Cell compound. Hepatic fat accumulation can progress from simple NAFLD to non-alcoholic steatohepatitis  which includes hepatocellular injury, inflammation, and fibrosis. In more severe cases, complications such as liver cirrhosis and hepatocellular carcinoma may arise. NASH, the more severe form of NAFLD, affects 3-5% of US adult population.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/bioharvest-vitro-testing-shows-proprietary-133000517.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bioharvest-vitro-testing-shows-proprietary-133000517.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BHST","CDMO","BK4183","BK4139"],"gpt_icon":0},{"id":"2516665945","title":"Full-Year 2024 Results - Progress on the implementation of the FOCUS-27 plan driven by enhanced effectiveness and financial discipline","url":"https://stock-news.laohu8.com/highlight/detail?id=2516665945","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516665945?lang=en_us&edition=fundamental","pubTime":"2025-03-04 01:35","pubTimestamp":1741023300,"startTime":"0","endTime":"0","summary":"Full-year 2024 results1: Operational resilience and strong increase in Free Cash Flow before financing in a challenging environment. Net sales down 10.0% to 911.9 million, driven by lower volumes for Sanofi and the suspension of production at Brindisi, only partly offset by encouraging commercial momentum. Core EBITDA at 50.4m, with margin down 370bps year-on-year to 5.5%, due notably to unfavorable fixed cost impact.  million EBITDA, including 87.1 million exceptional costs related to the implementation of FOCUS-27. Cash Flow before financing at 15.0 million, up from  million in 2023, driven by tight inventory management  and improved cash collection, more than offsetting lower EBITDA. Annual run-rate incremental Core EBITDA target of 75-80m by the end of 2027 confirmed2. Core EBITDA margin should improve, driven by increased industrial, procurement, and operational efficiencies, and should reach between 7% and 9% of net sales.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/full-2024-results-progress-implementation-173500390.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4142","BK4585","SG9999014005.SGD","SG9999014021.USD","BK4007","BK4532","GHG","BK4154","CDMO","EBIT","EAPIF","LU2065732104.USD","SG9999014039.USD","BK4097","BK4588","BK4139","SG9999014013.SGD","MOH","PRGS"],"gpt_icon":0},{"id":"2514843445","title":"Market Chatter: South Korea Aims to Be Among Top Five Global Bio Leaders","url":"https://stock-news.laohu8.com/highlight/detail?id=2514843445","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514843445?lang=en_us&edition=fundamental","pubTime":"2025-02-27 12:28","pubTimestamp":1740630491,"startTime":"0","endTime":"0","summary":"South Korea's Acting President Choi Sang-mok reaffirmed the country's ambition to rank among the world's top five leaders in the advanced bio sector by 2035, Yonhap News reported Wednesday.Choi stressed public-private cooperation and urged leadership in the contract development and manufacturing organization  industry, with plans to expand domestic CDMO capacity 2.5 times and become the top global CDMO player by 2032, the report said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","CDMO"],"gpt_icon":0},{"id":"2514898573","title":"Lifecore Biomedical to Participate in Upcoming Investor and Industry Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2514898573","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514898573?lang=en_us&edition=fundamental","pubTime":"2025-02-27 05:05","pubTimestamp":1740603900,"startTime":"0","endTime":"0","summary":"CHASKA, Minn., Feb. 26, 2025  -- Lifecore Biomedical, Inc.  , a fully integrated contract development and manufacturing organization , today announced that the company will participate in multiple upcoming investor conferences and industry events. Details regarding Lifecore’s participation are as follows:. KeyBanc Capital Markets Healthcare ForumDetails: Mr. Josephs will participate in a fireside chat and Lifecore management will participate in investor meetingsFireside Chat Date/Time: Wednesday, March 19, 2025, 3:00 – 3:35 p.m. ETConference Dates: March 18-19, 2025Location: Virtual. DCAT Week 2025Details: Lifecore team will participate in meetings with current and prospective customers and attend networking eventsConference Dates: March 17-20, 2025Location: New York, NY. Lifecore Biomedical, Inc.  is a fully integrated contract development and manufacturing organization  that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceut","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lifecore-biomedical-participate-upcoming-investor-210500811.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CFO","LFCR","BK4139","CDMO","BK4212","BK4121"],"gpt_icon":0},{"id":"2514830775","title":"Scorpius Holdings Engages Alliance Global Partners to Explore Strategic Alternatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2514830775","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514830775?lang=en_us&edition=fundamental","pubTime":"2025-02-26 21:30","pubTimestamp":1740576600,"startTime":"0","endTime":"0","summary":"DURHAM, N.C., Feb.  26, 2025  (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization (\"CDMO\")","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/26/3032917/32418/en/Scorpius-Holdings-Engages-Alliance-Global-Partners-to-Explore-Strategic-Alternatives.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDMO","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":2,"totalSize":174,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CDMO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-06","symbol":"CDMO","reason":null,"defaultRemindTime":1738852200000,"announcedDate":"2025-02-04","type":"delisting","dateTimestamp":1738818000000},{"market":"US","date":"2024-12-10","symbol":"CDMO","fiscalQuarterEnding":"2024/10","expectedEps":-0.13,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1733806800000,"reportTimeType":"post","actualEps":-0.27},{"market":"US","date":"2024-09-09","symbol":"CDMO","fiscalQuarterEnding":"2024/07","expectedEps":-0.08,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1725854400000,"reportTimeType":"post","actualEps":-0.07},{"market":"US","date":"2024-07-02","symbol":"CDMO","fiscalQuarterEnding":"2024/04","expectedEps":0.03,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1719892800000,"reportTimeType":"post","actualEps":-0.07},{"market":"US","date":"2024-04-24","symbol":"CDMO","fiscalQuarterEnding":"2024/01","expectedEps":-0.02,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1713931200000,"reportTimeType":"post","actualEps":-0.08}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CDMO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CDMO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":3,"updateTime":1733374800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CDMO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CDMO","date":"2025-02-04","current":-5.249997,"percent":0.349064,"low":-236.80087,"twenty":-41.718676,"median":8.253213,"eighty":139.458758,"high":9284.394324,"avg":397.880667,"sd":1431.818994,"marketCap":798262008},"quantilePoints":[{"date":"2020-05-15","current":-58.462505,"twenty":-66.904816,"median":-6.237055,"eighty":-2.504068,"marketCap":313475954},{"date":"2020-05-22","current":-55.723721,"twenty":-66.904816,"median":-6.237055,"eighty":-2.504068,"marketCap":298790594},{"date":"2020-05-29","current":-61.517303,"twenty":-66.904816,"median":-6.237055,"eighty":-2.504068,"marketCap":329855779},{"date":"2020-06-05","current":-67.942912,"twenty":-67.634265,"median":-6.237055,"eighty":-2.504068,"marketCap":364309893},{"date":"2020-06-12","current":-60.463924,"twenty":-67.634265,"median":-6.237055,"eighty":-2.504068,"marketCap":324207563},{"date":"2020-06-19","current":-59.305208,"twenty":-67.634265,"median":-6.237055,"eighty":-2.504068,"marketCap":317994527},{"date":"2020-06-26","current":-62.465344,"twenty":-67.634265,"median":-6.237055,"eighty":-2.504068,"marketCap":334939173},{"date":"2020-07-02","current":-38.876487,"twenty":-67.634265,"median":-6.237055,"eighty":-2.504068,"marketCap":406881316},{"date":"2020-07-10","current":-37.526609,"twenty":-67.634265,"median":-6.237055,"eighty":-2.504068,"marketCap":392753493},{"date":"2020-07-17","current":-40.523339,"twenty":-67.634265,"median":-6.237055,"eighty":-2.504068,"marketCap":424117261},{"date":"2020-07-24","current":-36.662687,"twenty":-67.634265,"median":-6.237055,"eighty":-2.504068,"marketCap":383711686},{"date":"2020-07-31","current":-40.06438,"twenty":-67.634265,"median":-6.237055,"eighty":-2.504068,"marketCap":419313801},{"date":"2020-08-07","current":-41.738229,"twenty":-67.634265,"median":-6.237055,"eighty":-2.504068,"marketCap":436832302},{"date":"2020-08-14","current":-45.841858,"twenty":-67.634265,"median":-6.237055,"eighty":-2.504068,"marketCap":479780886},{"date":"2020-08-21","current":-45.031931,"twenty":-67.634265,"median":-6.237055,"eighty":-2.504068,"marketCap":471304191},{"date":"2020-08-28","current":-45.916081,"twenty":-67.634265,"median":-6.237055,"eighty":-2.504068,"marketCap":480557704},{"date":"2020-09-04","current":-149.319573,"twenty":-67.942912,"median":-6.237055,"eighty":-2.504068,"marketCap":384049943},{"date":"2020-09-11","current":-158.01246,"twenty":-68.84612,"median":-6.237055,"eighty":-2.504068,"marketCap":406408046},{"date":"2020-09-18","current":-174.517939,"twenty":-69.166335,"median":-6.273961,"eighty":-2.504068,"marketCap":448860140},{"date":"2020-09-25","current":-165.054798,"twenty":-69.619972,"median":-6.314377,"eighty":-2.504068,"marketCap":424520940},{"date":"2020-10-02","current":-165.054798,"twenty":-70.073609,"median":-6.352234,"eighty":-2.504068,"marketCap":424520940},{"date":"2020-10-09","current":-176.938743,"twenty":-70.407166,"median":-6.396225,"eighty":-2.504068,"marketCap":455086447},{"date":"2020-10-16","current":-176.278524,"twenty":-70.847461,"median":-6.421583,"eighty":-2.504068,"marketCap":453388363},{"date":"2020-10-23","current":-180.459912,"twenty":-71.381152,"median":-6.5323,"eighty":-2.504068,"marketCap":464142894},{"date":"2020-10-30","current":-159.552971,"twenty":-71.701366,"median":-6.587659,"eighty":-2.504068,"marketCap":410370242},{"date":"2020-11-06","current":-183.761008,"twenty":-72.235057,"median":-6.662048,"eighty":-2.504068,"marketCap":472633313},{"date":"2020-11-13","current":-196.305173,"twenty":-73.622653,"median":-6.679923,"eighty":-2.504068,"marketCap":504896904},{"date":"2020-11-20","current":-197.845684,"twenty":-75.073301,"median":-6.772187,"eighty":-2.504068,"marketCap":508859100},{"date":"2020-11-27","current":-196.745319,"twenty":-76.904852,"median":-6.782203,"eighty":-2.504068,"marketCap":506028960},{"date":"2020-12-04","current":4498.158592,"twenty":-77.30512,"median":-6.772187,"eighty":-2.483106,"marketCap":638738520},{"date":"2020-12-11","current":4438.917085,"twenty":-77.30512,"median":-6.716829,"eighty":-2.406889,"marketCap":630326226},{"date":"2020-12-18","current":4853.303049,"twenty":-77.30512,"median":-6.716829,"eighty":-2.282345,"marketCap":689169033},{"date":"2020-12-24","current":4857.56781,"twenty":-77.30512,"median":-6.716829,"eighty":-2.161884,"marketCap":689774629},{"date":"2020-12-31","current":4921.539296,"twenty":-77.30512,"median":-6.716829,"eighty":-2.109644,"marketCap":698858580},{"date":"2021-01-08","current":5608.166528,"twenty":-77.30512,"median":-6.716829,"eighty":-2.071578,"marketCap":796359647},{"date":"2021-01-15","current":5770.227613,"twenty":-77.30512,"median":-6.716829,"eighty":-2.052613,"marketCap":819372321},{"date":"2021-01-22","current":6077.290725,"twenty":-77.30512,"median":-6.716829,"eighty":-2.039121,"marketCap":862975283},{"date":"2021-01-29","current":6222.292746,"twenty":-77.30512,"median":-6.716829,"eighty":-2.028206,"marketCap":883565570},{"date":"2021-02-05","current":7774.667359,"twenty":-77.30512,"median":-6.716829,"eighty":-2.00864,"marketCap":1104002765},{"date":"2021-02-12","current":7642.459634,"twenty":-77.30512,"median":-6.716829,"eighty":-1.981915,"marketCap":1085229268},{"date":"2021-02-19","current":7616.871042,"twenty":-77.30512,"median":-6.716829,"eighty":-1.967528,"marketCap":1081595688},{"date":"2021-02-26","current":8776.887239,"twenty":-77.30512,"median":-6.716829,"eighty":-1.953306,"marketCap":1246317988},{"date":"2021-03-05","current":7574.223387,"twenty":-77.331805,"median":-6.744508,"eighty":-1.945514,"marketCap":1075539721},{"date":"2021-03-12","current":236.593569,"twenty":-77.331805,"median":-6.744508,"eighty":-1.937875,"marketCap":1053551161},{"date":"2021-03-19","current":246.292266,"twenty":-77.331805,"median":-6.744508,"eighty":-1.928906,"marketCap":1096739459},{"date":"2021-03-26","current":230.173304,"twenty":-77.278436,"median":-6.698376,"eighty":-1.924277,"marketCap":1024961724},{"date":"2021-04-01","current":262.001423,"twenty":-77.278436,"median":-6.698376,"eighty":-1.907206,"marketCap":1166692337},{"date":"2021-04-09","current":264.870052,"twenty":-77.30512,"median":-6.716829,"eighty":-1.906724,"marketCap":1179466340},{"date":"2021-04-16","current":261.72822,"twenty":-77.30512,"median":-6.716829,"eighty":-1.903436,"marketCap":1165475765},{"date":"2021-04-23","current":289.594899,"twenty":-77.30512,"median":-6.716829,"eighty":-1.897813,"marketCap":1289566086},{"date":"2021-04-30","current":292.395227,"twenty":-77.30512,"median":-6.716829,"eighty":-1.888555,"marketCap":1302035947},{"date":"2021-05-07","current":277.300776,"twenty":-77.30512,"median":-6.716829,"eighty":-1.888555,"marketCap":1234820356},{"date":"2021-05-14","current":274.432148,"twenty":-77.30512,"median":-6.716829,"eighty":-1.888555,"marketCap":1222046353},{"date":"2021-05-21","current":274.295546,"twenty":-77.30512,"median":-6.716829,"eighty":-1.888362,"marketCap":1221438067},{"date":"2021-05-28","current":290.68771,"twenty":-77.30512,"median":-6.716829,"eighty":-1.871961,"marketCap":1294432373},{"date":"2021-06-04","current":316.095565,"twenty":-77.30512,"median":-6.716829,"eighty":-1.85901,"marketCap":1407573549},{"date":"2021-06-11","current":315.68576,"twenty":-77.30512,"median":-6.716829,"eighty":-1.848648,"marketCap":1405748691},{"date":"2021-06-18","current":316.095565,"twenty":-77.30512,"median":-6.716829,"eighty":-1.841619,"marketCap":1407573549},{"date":"2021-06-25","current":342.869433,"twenty":-77.30512,"median":-6.716829,"eighty":-1.832157,"marketCap":1526797583},{"date":"2021-07-02","current":142.499473,"twenty":-77.30512,"median":-6.716829,"eighty":-1.830139,"marketCap":1597704096},{"date":"2021-07-09","current":141.845556,"twenty":-77.30512,"median":-6.716829,"eighty":-1.821934,"marketCap":1590372376},{"date":"2021-07-16","current":136.83219,"twenty":-77.30512,"median":-6.716829,"eighty":-1.81215,"marketCap":1534162518},{"date":"2021-07-23","current":141.355118,"twenty":-77.30512,"median":-6.716829,"eighty":-1.799525,"marketCap":1584873585},{"date":"2021-07-30","current":139.774818,"twenty":-77.30512,"median":-6.716829,"eighty":-1.785372,"marketCap":1567155261},{"date":"2021-08-06","current":141.73657,"twenty":-77.30512,"median":-6.716829,"eighty":-1.764864,"marketCap":1589150422},{"date":"2021-08-13","current":136.723204,"twenty":-77.30512,"median":-6.716829,"eighty":-1.688839,"marketCap":1532940565},{"date":"2021-08-20","current":135.142904,"twenty":-77.30512,"median":-6.716829,"eighty":-1.617566,"marketCap":1515222240},{"date":"2021-08-27","current":132.180722,"twenty":-77.30512,"median":-6.716829,"eighty":-1.602452,"marketCap":1482010253},{"date":"2021-09-03","current":126.490823,"twenty":-77.30512,"median":-6.716829,"eighty":-1.594862,"marketCap":1418215110},{"date":"2021-09-10","current":101.036419,"twenty":-77.30512,"median":-6.716829,"eighty":-1.573195,"marketCap":1291851653},{"date":"2021-09-17","current":100.652615,"twenty":-77.30512,"median":-6.716829,"eighty":-1.534217,"marketCap":1286944334},{"date":"2021-09-24","current":105.881945,"twenty":-77.30512,"median":-6.716829,"eighty":-1.523573,"marketCap":1353806551},{"date":"2021-10-01","current":101.180345,"twenty":-77.30512,"median":-6.716829,"eighty":-1.517157,"marketCap":1293691897},{"date":"2021-10-08","current":108.088819,"twenty":-77.30512,"median":-6.716829,"eighty":-1.495908,"marketCap":1382023634},{"date":"2021-10-15","current":123.728834,"twenty":-77.30512,"median":-6.716829,"eighty":-1.484858,"marketCap":1581996872},{"date":"2021-10-22","current":124.73632,"twenty":-77.30512,"median":-6.716829,"eighty":-1.475257,"marketCap":1594878584},{"date":"2021-10-29","current":147.188857,"twenty":-77.30512,"median":-6.716829,"eighty":-1.460883,"marketCap":1881956729},{"date":"2021-11-05","current":163.980285,"twenty":-77.30512,"median":-6.716829,"eighty":-1.456578,"marketCap":2096651923},{"date":"2021-11-12","current":161.677461,"twenty":-77.30512,"median":-6.716829,"eighty":-1.445734,"marketCap":2067208010},{"date":"2021-11-19","current":161.677461,"twenty":-77.30512,"median":-6.716829,"eighty":-1.434782,"marketCap":2067208010},{"date":"2021-11-26","current":150.930947,"twenty":-77.30512,"median":-6.716829,"eighty":-1.432053,"marketCap":1929803086},{"date":"2021-12-03","current":138.697192,"twenty":-77.30512,"median":-6.716829,"eighty":92.966939,"marketCap":1773382302},{"date":"2021-12-10","current":116.804545,"twenty":-77.30512,"median":-6.716829,"eighty":99.366871,"marketCap":1638066942},{"date":"2021-12-17","current":114.169856,"twenty":-77.30512,"median":-6.716829,"eighty":101.093989,"marketCap":1601118064},{"date":"2021-12-23","current":129.714521,"twenty":-77.30512,"median":-6.716829,"eighty":102.54285,"marketCap":1819116446},{"date":"2021-12-31","current":128.133708,"twenty":-77.30512,"median":-6.716829,"eighty":106.764695,"marketCap":1796947119},{"date":"2022-01-07","current":97.527404,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1367724315},{"date":"2022-01-14","current":92.08238,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1291363300},{"date":"2022-01-21","current":79.918899,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1120782644},{"date":"2022-01-28","current":76.537715,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1073364917},{"date":"2022-02-04","current":85.056543,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1192832957},{"date":"2022-02-11","current":93.180167,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1306758666},{"date":"2022-02-18","current":85.012631,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1192217143},{"date":"2022-02-25","current":88.876842,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1246408831},{"date":"2022-03-04","current":81.148421,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1138025454},{"date":"2022-03-11","current":81.564879,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1147210023},{"date":"2022-03-18","current":96.139443,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1352201265},{"date":"2022-03-25","current":94.690766,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1331825629},{"date":"2022-04-01","current":94.602968,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1330590742},{"date":"2022-04-08","current":83.057455,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1168203102},{"date":"2022-04-14","current":80.379598,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1130539048},{"date":"2022-04-22","current":75.418979,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1060767933},{"date":"2022-04-29","current":59.088443,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":831078951},{"date":"2022-05-06","current":55.444802,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":779831140},{"date":"2022-05-13","current":54.96191,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":773039262},{"date":"2022-05-20","current":55.5765,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":781683471},{"date":"2022-05-27","current":60.449321,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":850219699},{"date":"2022-06-03","current":58.868947,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":827991733},{"date":"2022-06-10","current":55.620399,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":782300914},{"date":"2022-06-17","current":58.561652,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":823669629},{"date":"2022-06-24","current":68.52679,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":963829303},{"date":"2022-07-01","current":7.424698,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":947926104},{"date":"2022-07-08","current":8.766278,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1119208251},{"date":"2022-07-15","current":8.766278,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1119208251},{"date":"2022-07-22","current":8.48537,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1083344119},{"date":"2022-07-29","current":9.516981,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1215052051},{"date":"2022-08-05","current":9.376527,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1197119985},{"date":"2022-08-12","current":9.536354,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1217525439},{"date":"2022-08-19","current":8.950321,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1142705440},{"date":"2022-08-26","current":8.930948,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1140232052},{"date":"2022-09-02","current":7.824981,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":999030985},{"date":"2022-09-09","current":9.269592,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1139529431},{"date":"2022-09-16","current":8.637459,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1061820114},{"date":"2022-09-23","current":9.077423,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1115905799},{"date":"2022-09-30","current":9.669099,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1188641720},{"date":"2022-10-07","current":9.107766,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1119635846},{"date":"2022-10-14","current":8.925711,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1097255563},{"date":"2022-10-21","current":7.868786,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":967325584},{"date":"2022-10-28","current":8.971225,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1102850633},{"date":"2022-11-04","current":6.928173,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":851694119},{"date":"2022-11-11","current":7.767645,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":954892093},{"date":"2022-11-18","current":7.236653,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":889616266},{"date":"2022-11-25","current":7.438936,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":914483248},{"date":"2022-12-02","current":8.298636,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1020167920},{"date":"2022-12-09","current":6.812962,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":805660063},{"date":"2022-12-16","current":7.287183,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":861738490},{"date":"2022-12-23","current":7.202877,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":851768992},{"date":"2022-12-30","current":7.255568,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":857999928},{"date":"2023-01-06","current":7.740326,"twenty":-77.30512,"median":-6.679923,"eighty":109.283255,"marketCap":915324542},{"date":"2023-01-13","current":8.593922,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1016265710},{"date":"2023-01-20","current":8.66769,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1024989021},{"date":"2023-01-27","current":8.636075,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1021250459},{"date":"2023-02-03","current":8.530693,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1008788586},{"date":"2023-02-10","current":8.699305,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1028727583},{"date":"2023-02-17","current":8.720381,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1031219957},{"date":"2023-02-24","current":8.620268,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1019381178},{"date":"2023-03-03","current":9.015451,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1066113200},{"date":"2023-03-10","current":7.350412,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":869215613},{"date":"2023-03-17","current":9.559254,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1113337596},{"date":"2023-03-24","current":9.382032,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1092697068},{"date":"2023-03-31","current":10.074809,"twenty":-77.278436,"median":-6.596886,"eighty":109.201646,"marketCap":1173382770},{"date":"2023-04-06","current":10.203698,"twenty":-77.278436,"median":-6.596886,"eighty":109.201646,"marketCap":1188394064},{"date":"2023-04-14","current":11.240179,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1309109882},{"date":"2023-04-21","current":10.289624,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1198401592},{"date":"2023-04-28","current":9.50555,"twenty":-77.30512,"median":-6.513848,"eighty":109.283255,"marketCap":1107082891},{"date":"2023-05-05","current":9.919068,"twenty":-77.30512,"median":-6.458489,"eighty":109.283255,"marketCap":1155244124},{"date":"2023-05-10","current":9.731105,"twenty":-77.30512,"median":-6.403131,"eighty":109.283255,"marketCap":1133352654},{"date":"2023-05-19","current":7.835366,"twenty":-77.358489,"median":-6.20015,"eighty":109.446474,"marketCap":912561547},{"date":"2023-05-26","current":8.168329,"twenty":-77.358489,"median":-6.107885,"eighty":109.446474,"marketCap":951340721},{"date":"2023-06-02","current":8.367032,"twenty":-77.358489,"median":-6.034074,"eighty":109.446474,"marketCap":974483132},{"date":"2023-06-09","current":9.194069,"twenty":-77.358489,"median":6.812962,"eighty":109.446474,"marketCap":1070805598},{"date":"2023-06-16","current":9.118884,"twenty":-77.385174,"median":6.991758,"eighty":109.528084,"marketCap":1062049010},{"date":"2023-06-23","current":1539.104598,"twenty":-77.386973,"median":7.174145,"eighty":110.625618,"marketCap":861898575},{"date":"2023-06-30","current":1496.538387,"twenty":-77.387872,"median":7.239761,"eighty":113.886744,"marketCap":838061497},{"date":"2023-07-07","current":1540.224762,"twenty":-77.387872,"median":7.287183,"eighty":118.166944,"marketCap":862525867},{"date":"2023-07-14","current":1497.65855,"twenty":-77.387872,"median":7.366219,"eighty":123.628937,"marketCap":838688788},{"date":"2023-07-21","current":1453.972175,"twenty":-77.387872,"median":7.424698,"eighty":125.174074,"marketCap":814224418},{"date":"2023-07-28","current":1438.289888,"twenty":-77.387872,"median":7.44905,"eighty":127.470924,"marketCap":805442337},{"date":"2023-08-04","current":1365.479263,"twenty":-77.387872,"median":7.624406,"eighty":129.89895,"marketCap":764668387},{"date":"2023-08-11","current":1437.169723,"twenty":-77.387872,"median":7.767645,"eighty":131.557258,"marketCap":804815045},{"date":"2023-08-18","current":1394.603513,"twenty":-77.387872,"median":7.840439,"eighty":132.799398,"marketCap":780977967},{"date":"2023-08-25","current":1319.552561,"twenty":-77.387872,"median":7.919356,"eighty":135.055715,"marketCap":738949434},{"date":"2023-09-01","current":1329.87968,"twenty":-77.387872,"median":8.066292,"eighty":136.461637,"marketCap":744732621},{"date":"2023-09-08","current":-236.80087,"twenty":-77.627134,"median":8.093067,"eighty":136.864886,"marketCap":733372293},{"date":"2023-09-15","current":-215.810775,"twenty":-79.724891,"median":8.093067,"eighty":136.864886,"marketCap":668365971},{"date":"2023-09-22","current":-193.597957,"twenty":-81.00567,"median":8.093067,"eighty":136.864886,"marketCap":599572873},{"date":"2023-09-29","current":-198.081278,"twenty":-81.501661,"median":8.093067,"eighty":136.864886,"marketCap":613457718},{"date":"2023-10-06","current":-191.356296,"twenty":-82.284183,"median":8.093067,"eighty":136.864886,"marketCap":592630450},{"date":"2023-10-13","current":-167.309392,"twenty":-83.104206,"median":8.093067,"eighty":136.864886,"marketCap":518157188},{"date":"2023-10-20","current":-142.039764,"twenty":-83.374176,"median":8.093067,"eighty":136.864886,"marketCap":439897149},{"date":"2023-10-27","current":-132.257973,"twenty":-83.539844,"median":8.114625,"eighty":137.082858,"marketCap":409602941},{"date":"2023-11-03","current":-125.125416,"twenty":-83.933555,"median":8.114625,"eighty":137.082858,"marketCap":387513414},{"date":"2023-11-10","current":-107.599706,"twenty":-84.748881,"median":8.114625,"eighty":137.082858,"marketCap":333236291},{"date":"2023-11-17","current":-105.561833,"twenty":-85.333644,"median":8.114625,"eighty":137.082858,"marketCap":326924998},{"date":"2023-11-24","current":-111.87924,"twenty":-85.931432,"median":8.114625,"eighty":137.082858,"marketCap":346490007},{"date":"2023-12-01","current":-103.727747,"twenty":-86.304259,"median":8.114625,"eighty":137.082858,"marketCap":321244834},{"date":"2023-12-08","current":-29.21466,"twenty":-87.127444,"median":8.103884,"eighty":136.886683,"marketCap":334507860},{"date":"2023-12-15","current":-32.03385,"twenty":-87.127444,"median":8.103884,"eighty":136.886683,"marketCap":366787580},{"date":"2023-12-22","current":-35.402927,"twenty":-87.127444,"median":8.103884,"eighty":136.886683,"marketCap":405363515},{"date":"2023-12-29","current":-37.501697,"twenty":-87.127444,"median":8.114625,"eighty":137.082858,"marketCap":429394426},{"date":"2024-01-05","current":-33.911696,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":388288921},{"date":"2024-01-12","current":-37.336004,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":427497248},{"date":"2024-01-19","current":-33.746004,"twenty":-87.127444,"median":8.138341,"eighty":137.475209,"marketCap":386391744},{"date":"2024-01-26","current":-38.219697,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":437615526},{"date":"2024-02-02","current":-36.397081,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":416746578},{"date":"2024-02-09","current":-36.562773,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":418643755},{"date":"2024-02-16","current":-42.527697,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":486942132},{"date":"2024-02-23","current":-44.12939,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":505281511},{"date":"2024-03-01","current":-42.417236,"twenty":-87.127444,"median":8.114625,"eighty":137.082858,"marketCap":485677347},{"date":"2024-03-08","current":-33.690773,"twenty":-87.127444,"median":8.114625,"eighty":137.082858,"marketCap":385759351},{"date":"2024-03-15","current":-33.635542,"twenty":-86.304259,"median":8.114625,"eighty":137.082858,"marketCap":385126959},{"date":"2024-03-22","current":-37.943543,"twenty":-85.931432,"median":8.114625,"eighty":137.082858,"marketCap":434453565},{"date":"2024-03-28","current":-38.551081,"twenty":-85.333644,"median":8.114625,"eighty":137.082858,"marketCap":441409881},{"date":"2024-04-05","current":-35.016312,"twenty":-84.693001,"median":8.125366,"eighty":137.279033,"marketCap":400936768},{"date":"2024-04-12","current":-38.109235,"twenty":-83.840428,"median":8.125366,"eighty":137.279033,"marketCap":436350742},{"date":"2024-04-19","current":-36.010466,"twenty":-83.520355,"median":8.125366,"eighty":137.279033,"marketCap":412319831},{"date":"2024-04-26","current":-26.277899,"twenty":-83.301704,"median":8.114625,"eighty":137.082858,"marketCap":464672092},{"date":"2024-05-03","current":-29.436991,"twenty":-82.558967,"median":8.114625,"eighty":137.082858,"marketCap":520534310},{"date":"2024-05-10","current":-29.221598,"twenty":-82.027926,"median":8.114625,"eighty":137.082858,"marketCap":516725523},{"date":"2024-05-17","current":-33.026868,"twenty":-81.364604,"median":8.114625,"eighty":137.082858,"marketCap":584014104},{"date":"2024-05-24","current":-31.698613,"twenty":-80.745541,"median":8.114625,"eighty":137.082858,"marketCap":560526581},{"date":"2024-05-31","current":-28.539522,"twenty":-79.544946,"median":8.114625,"eighty":137.082858,"marketCap":504664362},{"date":"2024-06-07","current":-28.826712,"twenty":-77.386073,"median":8.114625,"eighty":137.082858,"marketCap":509742745},{"date":"2024-06-14","current":-24.770151,"twenty":-75.623994,"median":8.125366,"eighty":137.279033,"marketCap":438010578},{"date":"2024-06-21","current":-24.447062,"twenty":-74.423568,"median":8.138341,"eighty":137.475209,"marketCap":432297397},{"date":"2024-06-28","current":-25.165037,"twenty":-73.302439,"median":8.168329,"eighty":137.998343,"marketCap":444993355},{"date":"2024-07-05","current":-3.47825,"twenty":-72.208373,"median":8.168329,"eighty":137.998343,"marketCap":489574115},{"date":"2024-07-12","current":-3.613766,"twenty":-71.674682,"median":8.168329,"eighty":137.998343,"marketCap":508648432},{"date":"2024-07-15","current":-3.758317,"twenty":-71.647997,"median":8.168329,"eighty":137.998343,"marketCap":528994369},{"date":"2024-08-02","current":-4.729516,"twenty":-70.687354,"median":8.235305,"eighty":139.297726,"marketCap":665693635},{"date":"2024-08-09","current":-4.774689,"twenty":-70.233717,"median":8.235305,"eighty":139.297726,"marketCap":672051740},{"date":"2024-08-16","current":-4.824378,"twenty":-69.886817,"median":8.235305,"eighty":139.297726,"marketCap":679045656},{"date":"2024-08-23","current":-4.810826,"twenty":-69.379811,"median":8.235305,"eighty":139.297726,"marketCap":677138225},{"date":"2024-08-30","current":-4.695582,"twenty":-68.84612,"median":8.235305,"eighty":139.297726,"marketCap":660917318},{"date":"2024-09-06","current":-4.079174,"twenty":-68.285745,"median":8.235305,"eighty":139.297726,"marketCap":574155972},{"date":"2024-09-13","current":-4.938462,"twenty":-67.912161,"median":8.235305,"eighty":139.297726,"marketCap":711953405},{"date":"2024-09-20","current":-5.509306,"twenty":-66.964853,"median":8.235305,"eighty":139.297726,"marketCap":794249094},{"date":"2024-09-27","current":-4.942887,"twenty":-65.87829,"median":8.235305,"eighty":139.297726,"marketCap":712591356},{"date":"2024-10-04","current":-4.672953,"twenty":-64.235019,"median":8.235305,"eighty":139.297726,"marketCap":673676340},{"date":"2024-10-11","current":-4.500373,"twenty":-63.139506,"median":8.235305,"eighty":139.297726,"marketCap":648796248},{"date":"2024-10-18","current":-4.491523,"twenty":-61.770113,"median":8.235305,"eighty":139.297726,"marketCap":647520346},{"date":"2024-10-25","current":-4.518073,"twenty":-60.358586,"median":8.235305,"eighty":139.297726,"marketCap":651348052},{"date":"2024-10-31","current":-4.491523,"twenty":-59.28414,"median":8.235305,"eighty":139.297726,"marketCap":647520346},{"date":"2024-11-08","current":-5.416378,"twenty":-57.72514,"median":8.243207,"eighty":139.447859,"marketCap":780852121},{"date":"2024-11-15","current":-5.292495,"twenty":-55.723721,"median":8.243207,"eighty":139.447859,"marketCap":762992503},{"date":"2024-11-22","current":-5.434456,"twenty":-53.82764,"median":8.243207,"eighty":139.447859,"marketCap":783458354},{"date":"2024-11-29","current":-5.447765,"twenty":-50.035478,"median":8.243207,"eighty":139.447859,"marketCap":785377027},{"date":"2024-12-06","current":-5.452201,"twenty":-48.666086,"median":8.243207,"eighty":139.447859,"marketCap":786016585},{"date":"2024-12-13","current":-5.178482,"twenty":-47.296694,"median":8.243207,"eighty":139.447859,"marketCap":787388247},{"date":"2024-12-20","current":-5.186896,"twenty":-46.111834,"median":8.243207,"eighty":139.447859,"marketCap":788667513},{"date":"2024-12-27","current":-5.165862,"twenty":-45.841544,"median":8.243207,"eighty":139.447859,"marketCap":785469348},{"date":"2025-01-03","current":-5.182689,"twenty":-45.510159,"median":8.243207,"eighty":139.447859,"marketCap":788027880},{"date":"2025-01-10","current":-5.207929,"twenty":-44.898573,"median":8.253213,"eighty":139.458758,"marketCap":791865678},{"date":"2025-01-17","current":-5.207929,"twenty":-44.137114,"median":8.253213,"eighty":139.458758,"marketCap":791865678},{"date":"2025-01-24","current":-5.237377,"twenty":-43.29527,"median":8.253213,"eighty":139.458758,"marketCap":796343109},{"date":"2025-01-31","current":-5.241583,"twenty":-42.152128,"median":8.253213,"eighty":139.458758,"marketCap":796982742},{"date":"2025-02-04","current":-5.249997,"twenty":-41.718676,"median":8.253213,"eighty":139.458758,"marketCap":798262008}],"updateTime":1746950560132}}}